Literature DB >> 29322218

[Paraneoplasms of the skin].

C Gießen-Jung1, A Wollenberg2, M Reinholz2.   

Abstract

The cutaneous manifestations of malignancies include nonmalignant skin disorders that occur in association with malignancies (facultative paraneoplastic dermatoses) and skin disorders that are always associated with hematologic diseases or solid tumors (obligate paraneoplastic dermatoses). Paraneoplastic increase of growth factors or immunological reactions lead to a variety of inflammatory, hyperkeratotic or proliferative skin reactions. When paraneoplastic dermatoses develop before cancer is diagnosed, recognition of these skin diseases can accelerate both the diagnosis and treatment. The presence of unexplained cutaneous findings should lead to a multidisciplinary evaluation of the patient. This manuscript summarizes the cutaneous manifestations associated with hematologic disorders and solid tumors, their localization and treatment options.

Entities:  

Keywords:  Acanthosis nigricans; Dermatomyositis; Exanthema; Hematologic neoplasms; Pemphigus

Mesh:

Year:  2018        PMID: 29322218     DOI: 10.1007/s00108-017-0372-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  38 in total

Review 1.  [Cutaneous paraneoplasia].

Authors:  H Wolff
Journal:  Internist (Berl)       Date:  2001-05       Impact factor: 0.743

2.  Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes.

Authors:  D L Ellis; S P Kafka; J C Chow; L B Nanney; W H Inman; M E McCadden; L E King
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

Review 3.  Acquired ichthyosis.

Authors:  Nisha Patel; Lori A Spencer; Joseph C English; Matthew J Zirwas
Journal:  J Am Acad Dermatol       Date:  2006-10       Impact factor: 11.527

4.  Toward a definition of cutaneous paraneoplastic syndrome.

Authors:  D I McLean
Journal:  Clin Dermatol       Date:  1993 Jan-Mar       Impact factor: 3.541

5.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

Review 6.  Acquired hypertrichosis lanuginosa associated with malignancy.

Authors:  A L Hovenden
Journal:  Arch Intern Med       Date:  1987-11

7.  Acquired erythroderma in adults: a clinical and prognostic study.

Authors:  A Khaled; A Sellami; B Fazaa; M Kharfi; F Zeglaoui; M R Kamoun
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-12-17       Impact factor: 6.166

Review 8.  Malignancy-associated Sweet's syndrome: review of the world literature.

Authors:  P R Cohen; M Talpaz; R Kurzrock
Journal:  J Clin Oncol       Date:  1988-12       Impact factor: 44.544

9.  Erythroderma. A clinical and follow-up study of 102 patients, with special emphasis on survival.

Authors:  V Sigurdsson; J Toonstra; M Hezemans-Boer; W A van Vloten
Journal:  J Am Acad Dermatol       Date:  1996-07       Impact factor: 11.527

10.  Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.

Authors:  Sébastien Le Jan; Julie Plée; David Vallerand; Aurélie Dupont; Elodie Delanez; Anne Durlach; Patricia L Jackson; J Edwin Blalock; Philippe Bernard; Frank Antonicelli
Journal:  J Invest Dermatol       Date:  2014-07-19       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.